MKM Partners Assumes CNX Resources at Neutral, Announces Price Target of $16
MKM Partners analyst Leo Mariani assumes CNX Resources (NYSE:CNX) with a Neutral rating and announces Price Target of $16.
MKM Partners Assumes Occidental Petroleum at Neutral, Announces Price Target of $65
MKM Partners analyst Leo Mariani assumes Occidental Petroleum (NYSE:OXY) with a Neutral rating and announces Price Target of $65.
MKM Partners Assumes Centennial Resource Dev at Buy, Announces Price Target of $10
MKM Partners analyst Leo Mariani assumes Centennial Resource Dev (NASDAQ:CDEV) with a Buy rating and announces Price Target of $10.
Morgan Stanley Initiates Coverage On Sharecare with Equal-Weight Rating, Announces Price Target of $2.5
Morgan Stanley analyst Craig Hettenbach initiates coverage on Sharecare (NASDAQ:SHCR) with a Equal-Weight rating and announces Price Target of $2.5.
Goldman Sachs Initiates Coverage On Innoviva with Neutral Rating, Announces Price Target of $16
Goldman Sachs analyst Chris Shibutani initiates coverage on Innoviva (NASDAQ:INVA) with a Neutral rating and announces Price Target of $16.
SVB Leerink Initiates Coverage On Kymera Therapeutics with Market Perform Rating, Announces Price Target of $26
SVB Leerink analyst Mike Kratky initiates coverage on Kymera Therapeutics (NASDAQ:KYMR) with a Market Perform rating and announces Price Target of $26.
SVB Leerink Initiates Coverage On Morphic Holding with Outperform Rating, Announces Price Target of $45
SVB Leerink analyst Mike Kratky initiates coverage on Morphic Holding (NASDAQ:MORF) with a Outperform rating and announces Price Target of $45.
Berenberg Initiates Coverage On Cazoo Gr with Sell Rating, Announces Price Target of $0.49
Berenberg analyst Saim Saeed initiates coverage on Cazoo Gr (NYSE:CZOO) with a Sell rating and announces Price Target of $0.49.
Bernstein Initiates Coverage On Twilio with Market Perform Rating, Announces Price Target of $91
Bernstein analyst Peter Weed initiates coverage on Twilio (NYSE:TWLO) with a Market Perform rating and announces Price Target of $91.
Canaccord Genuity Initiates Coverage On Arcellx with Buy Rating, Announces Price Target of $32
Canaccord Genuity analyst John Newman initiates coverage on Arcellx (NASDAQ:ACLX) with a Buy rating and announces Price Target of $32.